Oral antivirals access opens to more Aboriginal Australians The move will come in with PBS changes from 1 November, which also include a treatment for a rare genetic disease.
Warning over Japanese encephalitis numbers As the wet weather continues, infectious disease experts have suggested almost 750,000 people could be at risk from the mosquito-borne virus.
TGA approves Moderna as adolescent booster An ongoing study demonstrates that the booster produces a similar immune response in this cohort to adults aged 18–25, the regulator says.
How stress can increase the chances of long COVID People with psychological distress in the lead up to their COVID infection have more chance of ongoing symptoms, writes Dr Susannah Tye.
Coffee intake has ‘no apparent effect’ on IVF outcomes: Study New analysis suggests caffeine consumption has little impact on the success of fertility treatments but confirms the negative influence of alcohol.
RACGP backs up-schedule for modified release paracetamol The college is also supporting a proposal for smaller pack sizes but does not favour restricting over-the-counter sales to adults only.
New clinical support for ‘silent but deadly’ disease Chronic kidney disease detection and management resources have been released, days after it was labelled a ‘national emergency’.
Stronger myocarditis warnings after death linked to vaccine The stronger product information warning follows the death of a woman in her 20s, who died after receiving a Moderna booster.
How scrapped iso requirements impact telehealth The end of COVID isolation also means fewer exemptions to the 12-month telehealth rule.
PSA testing ‘dilemma’: A pathologist’s perspective Prostate cancer screening guidelines are typically debated by urologists and GPs, but a pathologist’s perspective adds extra nuance to a discussion often seen as black and white.